Clinical Trials Browser

Interventional × Solid Cancers × obinutuzumab × Clear all

NCT02174172 2020-05-12

A Study to Assess the Safety and Tolerability of Atezolizumab in Combination With Other Immune-Modulating Therapies in Participants With Locally Advanced or Metastatic Solid Tumors

Phase 1 Completed

Solid Cancers